Breaking News
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
Advances in radiation treatment help prolong, improve lives of people with anal cancer

Advances in radiation treatment help prolong, improve lives of people with anal cancer

image_pdfDownload PDFimage_print

Two recent studies find advances in radiation therapy are helping to prolong or improve the lives of people with anal cancer, including those whose cancer has advanced to stage IV. Both studies were published in the International Journal of Radiation Oncology * Biology * Physics (Red Journal), the flagship scientific journal of the American Society for Radiation Oncology (ASTRO).

One study, of patients with advanced-stage anal cancer whose disease has spread to the para-aortic lymph nodes, found that a combination of extended-field radiation therapy and chemotherapy could substantially improve overall survival and control the cancer without increasing serious side effects. A second study found that, for patients with locally advanced anal cancer, the use of intensity modulated radiation therapy (IMRT) instead of conventional radiation treatment improved tolerance of radiation treatments and reduced the need for ostomy (surgery to re-route how waste exits the body).

Anal canal cancer is relatively rare, with approximately 8,000 new cases diagnosed each year in the United States. Most anal canal cancers are squamous cell carcinomas (SCC) that have not yet spread to other parts of the body. Roughly 20 percent of anal SCC patients, however, are diagnosed with distant metastatic disease — also known as stage IV disease — each year.

Aggressive combination therapy prolongs survival for select patients with stage IV anal cancer

Patients with stage IV anal cancer typically have not been considered candidates for definitive treatment once their cancer had spread to other parts of their bodies. A new study shows that, if that cancer has spread only to the para-aortic lymph nodes, aggressive treatment in the form of extended-field radiation therapy could potentially improve their long-term outcomes.

“The label of ‘stage IV’ cancer is not one size fits all,” said lead researcher Emma B. Holliday, MD, an assistant professor in the department of radiation oncology at the University of Texas MD Anderson Cancer Center in Houston. “There are emerging data in several cancer types where aggressive treatment of metastatic disease can improve survival.”

“Although involvement of the para-aortic nodes is considered metastatic disease for squamous cell carcinoma of the anal canal, we have long suspected that these patients do not have the poor prognosis that accompanies a stage IV diagnosis in other cancers,” she said. “The results from this study showed that aggressive combination treatment with definitive extended-field chemoradiation can lead to good outcomes.”

It is common for SCC to spread to the pelvic and inguinal lymph nodes before moving on to the para-aortic (PA) lymph nodes. Dr. Holliday noted that her results were similar to previous studies of patients with SCC of the cervix who had been classified as stage IV due to metastases to the para-aortic lymph nodes.

In this retrospective review, Dr. Holliday and her team assessed long-term outcomes for 30 patients who were treated with curative-intent, extended-field chemoradiation — combined chemotherapy and radiation therapy — between September 2002 and February 2016 at the University of Texas MD Anderson Cancer Center in Houston and the Mayo Clinic in Rochester, Minnesota.

Over the course of the study, external beam radiation therapy techniques evolved. Therefore, some patients were treated with 3D conformal techniques during the early phase of the study and a few were treated with intensity modulated proton therapy during the later phases. The vast majority of patients, however, were treated with IMRT. For chemotherapy regimens, patients received either six weekly cycles of cisplatin with 5-fluoruracil/capecitabine (5-FU), two cycles of mitomycin-C with 5-FU or daily capecitabine.

After 3.1 years of follow-up, 18 of 30 patients remained alive and 17 showed no evidence of anal cancer. The overall survival rate was 67 percent (95% CI 49-89), with a disease-free survival rate of 42 percent (95% CI 25-69). Cancer recurred in 15 of the patients (50 percent), predominantly as distant metastases.

No patients died from side effects related to the aggressive combination therapy. The treatments were well tolerated, although patients undergoing chemoradiation treatment for anal cancer often experience severe (grade 3-4) hematologic side effects, such as the loss of red and white blood cells, increased susceptibility to infection and loss of blood platelets; gastrointestinal side effects, such as nausea, vomiting, diarrhea and loss of appetite; and/or skin reactions. Six patients (20 percent) in this study experienced severe hematologic problems, nine (30 percent) experienced severe gastrointestinal side effects and eight (27 percent) experienced severe skin reactions.

“I think we see that patients with para-aortic node metastases are potentially curable because these lymph nodes are the next echelon up from what we consider to be the regional lymph nodes in the pelvis,” said Dr. Holliday. “Most importantly, if we can deliver a curative dose of radiation to all sites of disease, we have the potential to extend survival for these patients.”

IMRT increases ability to complete treatment cycles, decreases need for breaks and additional surgery

Another recent study from the Red Journal examined how improvements in radiation therapy technology have led to fewer side effects and treatment interruptions for patients with locally advanced anal cancer. This review of a large clinical database found that a technologically advanced type of radiation — intensity modulated radiation therapy (IMRT) — could reduce toxicities for anal canal cancer patients treated with radiation.

“Using data from the national Veterans Affairs system of hospitals, we studied radiation toxicities among veterans with anal cancer and compared IMRT versus older forms of radiation therapy,” said lead researcher Alex K. Bryant, MD, a resident physician affiliated with the department of radiation medicine and applied sciences at the University of California, San Diego, School of Medicine. “We found that IMRT produced substantial benefits, including decreasing the need for treatment breaks and increasing chemotherapy completion rates.”

IMRT is a specialized type of radiation treatment that manipulates photon or proton beams of radiation into the shape of the targeted tumors, in order to limit radiation exposure to the healthy tissue surrounding the tumors.

Dr. Bryant and his team identified 779 patients in a national Veterans Affairs database who had been diagnosed with locally advanced anal SCC between 2000 and 2015. The patients had been treated with conventional radiation therapy (n=403) or IMRT (n=376), both with concurrent chemotherapy. The adoption of IMRT increased substantially during the study period; no patients received IMRT prior to 2004, compared to 89 percent of patients treated from 2012 to 2015.

The researchers found that patients treated with IMRT were 42 percent less likely to require a break from radiation treatment of more than five days. IMRT patients also had a 40 percent lower risk of needing ostomy surgery related to the cancer progressing or recurring.

Patients treated with IMRT also were more likely to receive and complete two cycles of chemotherapy, the standard treatment course. Overall, 19 percent (n=63) of patients who received IMRT were unable to complete two full cycles of chemotherapy, compared to 43 percent (n=153) treated with conventional radiation. The association of IMRT with completing standard chemotherapy remained significant even after controlling for patient and tumor characteristics.

“We were surprised that IMRT allowed more patients to complete a full course of chemotherapy,” said Dr. Bryant. “Previous studies have shown that the combination of radiation therapy and chemotherapy is very important for curing anal cancer, and we were encouraged that IMRT allowed more patients to undergo this potentially life-saving treatment.”

Researchers found no difference in short-term severe hematologic or gastrointestinal toxicity or long-term survival outcomes between the two radiation treatment groups. The study did not examine less severe toxicities.

“Though it was unclear why we saw a benefit for completing therapy, one possibility is that IMRT reduced toxicities that we were not able to measure – in particular, dermatologic toxicity and less severe forms of gastrointestinal and hematologic toxicity – and this allowed more patients to complete chemotherapy,” said Dr. Bryant. “Further research would be needed to determine whether there is a relationship between a reduction of those toxicities and completion of chemotherapy. If true, this would be a wonderful secondary benefit of IMRT and of great importance for patient outcomes.”

Source:

https://www.astro.org/News-and-Publications/News-and-Media-Center/News-Releases/2018/Advances-in-radiation-therapy-extend-and-improve-l

Tagged with:

About author

Related Articles